Nanping Luyan Pharmaceutical Co., Ltd. announced that it will receive CNY 38 million in equity round of funding on October 27, 2021. The transaction will include participation from existing investor Luyan Pharma Co.,Ltd. Upon closing, the registered capital of the company will increase from CNY 12 million to CNY 50 million. The transaction has been approved in the seventh meeting of the fifth board of directors of the investor.